• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Neumora Therapeutics, Inc. - Common Stock (NQ:NMRA)

1.960 -0.120 (-5.77%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 850,982
Open 2.060
Bid (Size) 1.950 (3)
Ask (Size) 2.040 (24)
Prev. Close 2.080
Today's Range 1.950 - 2.115
52wk Range 0.6110 - 17.19
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's After-Market Session
July 28, 2025
 
Via Benzinga
Boston Beer Posts Better-Than-Expected Earnings, Joins Scholastic, Deckers Outdoor, Saia And Other Big Stocks Moving Higher On Friday
July 25, 2025
 
Via Benzinga

Performance

YTD
-0.5%
-0.5%
1 Month
+146.1%
+146.1%
3 Month
+154.1%
+154.1%
6 Month
+2.1%
+2.1%
1 Year
-84.8%
-84.8%

More News

Read More
Neumora Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
July 23, 2025
From Neumora Therapeutics, Inc.
Via GlobeNewswire
Earnings Scheduled For May 12, 2025
May 12, 2025
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
July 18, 2025
Via Benzinga
These stocks are moving in today's session
July 09, 2025
Via Chartmill
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861
July 09, 2025
From Neumora Therapeutics, Inc.
Via GlobeNewswire
Let's uncover which stocks are experiencing notable gaps during today's session.
June 09, 2025
Via Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
May 19, 2025
Via Benzinga
Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
May 12, 2025
From Neumora Therapeutics, Inc.
Via GlobeNewswire
Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
April 28, 2025
From Neumora Therapeutics, Inc.
Via GlobeNewswire
NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
April 07, 2025
From The Schall Law Firm
Via Business Wire
Final NMRA Deadline Reminder: April 7, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
April 07, 2025
Via TheNewswire.com
Topics Lawsuit
Final NMRA Deadline Reminder: April 7, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
April 07, 2025
Via NewMediaWire
Topics Lawsuit
Faruqi & Faruqi Reminds Neumora Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - NMRA
April 06, 2025
From Faruqi & Faruqi LLP
Via GlobeNewswire
NMRA Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds Neumora Therapeutics, Inc. (NMRA) Investors of Filing Deadline in Class Action Lawsuit
April 03, 2025
Via NewMediaWire
Topics Lawsuit
NMRA Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds Neumora Therapeutics, Inc. (NMRA) Investors of Filing Deadline in Class Action Lawsuit
April 03, 2025
Via TheNewswire.com
Topics Lawsuit
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Neumora Therapeutics, Inc of Class Action Lawsuit and Upcoming Deadlines - NMRA
April 03, 2025
From Pomerantz LLP
Via GlobeNewswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics
April 02, 2025
From Faruqi & Faruqi LLP
Via GlobeNewswire
NMRA DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Neumora Therapeutics, Inc. Securities Fraud Class Action Lawsuit
April 01, 2025
Via NewMediaWire
Topics Fraud Lawsuit
NMRA DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Neumora Therapeutics, Inc. Securities Fraud Class Action Lawsuit
April 01, 2025
Via TheNewswire.com
Topics Fraud Lawsuit
NEUMORA THERAPEUTICS, INC. (NASDAQ: NMRA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Neumora Therapeutics, Inc. Investors of Upcoming Deadline
April 01, 2025
From Bernstein Liebhard LLP
Via GlobeNewswire
NMRA DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important April 7 Deadline in Securities Class Action First Filed by the Firm – NMRA
March 31, 2025
From The Rosen Law Firm PA
Via GlobeNewswire
Neumora Therapeutics, Inc. (NMRA) Investors: April 7, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
March 30, 2025
Via NewMediaWire
Topics Lawsuit
Neumora Therapeutics, Inc. (NMRA) Investors: April 7, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
March 30, 2025
Via TheNewswire.com
Topics Lawsuit

Frequently Asked Questions

Is Neumora Therapeutics, Inc. - Common Stock publicly traded?
Yes, Neumora Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Neumora Therapeutics, Inc. - Common Stock trade on?
Neumora Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Neumora Therapeutics, Inc. - Common Stock?
The ticker symbol for Neumora Therapeutics, Inc. - Common Stock is NMRA on the Nasdaq Stock Market
What is the current price of Neumora Therapeutics, Inc. - Common Stock?
The current price of Neumora Therapeutics, Inc. - Common Stock is 1.960
When was Neumora Therapeutics, Inc. - Common Stock last traded?
The last trade of Neumora Therapeutics, Inc. - Common Stock was at 07/31/25 04:00 PM ET
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap